VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study

VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study

Bibliographic Details
Main Authors:	Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias S. Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-04-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-024-01047-1

Similar Items

P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
by: Jakob Nordberg Nørgaard, et al.
Published: (2023-08-01)

PB2125: VCD VERSUS VRD‐BASED REGIMENS AS INDUCTION THERAPIES IN PATIENTS WITH PRIMARY MULTIPLE MYELOMA (MM): HIGHLIGHTING STRATEGIES THAT ACTUALLY WORK.
by: Olga Novosad, et al.
Published: (2023-08-01)

Incidence and prevention of skeletal‐related events in multiple myeloma patients: A population‐based real‐world experience
by: Marie Røra, et al.
Published: (2024-08-01)

New Targets for PET Imaging of Myeloma
by: Mona-Elisabeth Revheim, et al.
Published: (2021-12-01)

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
by: Carlyn Rose Tan, et al.
Published: (2023-07-01)

Neoplastic plasma cells with Auer rod‐like inclusions
by: Nordberg Nørgaard Jakob, et al.
Published: (2020-07-01)

P1671: CARFILZOMIB-DEXAMETHASONE MAINTENANCE HAMPERS RECOVERY AFTER SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
by: Lene Kongsgaard Nielsen, et al.
Published: (2023-08-01)

Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
by: Lene Kongsgaard Nielsen, et al.
Published: (2024-02-01)

Initial single centre experience with Barrel VRD stent in large neck aneurisms
by: Cristian Mihalea, et al.
Published: (2019-06-01)

Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
by: Kari Lenita Falck Moore, et al.
Published: (2022-10-01)

EVALUATION OF DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (D-VRD) INDUCTION FOLLOWED BY DARATUMUMAB AND LENALIDOMIDE (DR) MAINTENANCE IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS IN BRAZIL
by: JTD Souto-Filho, et al.
Published: (2024-10-01)

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)
by: Theo Leitner, et al.
Published: (2024-12-01)

Comparison of Time to Next Treatment or Death Between Front‐Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Among Transplant‐Ineligible Patients With Multiple Myeloma
by: Doris K. Hansen, et al.
Published: (2024-11-01)

Verifying the shear load capacity of vertically reinforced masonry walls by the VRd–NEd interaction diagram
by: Jasiński Radosław
Published: (2024-01-01)

EKSISTENSI PERDAGANGAN VCD/DVD BAJAKAN (Studi Kasus Perdagangan VCD/DVD Bajakan di Jl. Mataram, Yogyakarta)
by: , HANIK NURSICHAH, et al.
Published: (2013)

Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in a newly diagnosed multiple myeloma
by: Juan José Gil‐Fernández, et al.
Published: (2024-01-01)

Advances and challenges in anti-cancer vaccines for multiple myeloma
by: Pegah Abdollahi, et al.
Published: (2024-08-01)

P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
by: Frida Bugge Askeland, et al.
Published: (2023-08-01)

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
by: Nicolas Borisov, et al.
Published: (2021-04-01)

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
by: Tobias S. Slørdahl, et al.
Published: (2025-02-01)

P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
by: F. B. Askeland, et al.
Published: (2022-06-01)

Sistem penjualan VCD berasaskan web syarikat Beyond /
by: 235866 Anand Verdamanickam, et al.
Published: (2005)

Endocrine profile of the VCD-induced perimenopausal model rat.
by: Ruither O G Carolino, et al.
Published: (2019-01-01)

The Strucplot Framework: Visualizing Multi-way Contingency Tables with vcd
by: David Meyer, et al.
Published: (2006-10-01)

Potential value of pre-planned imaging of bone disease in multiple myeloma
by: Michael T. Gundesen, et al.
Published: (2023-07-01)

Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target
by: Tor Henrik Anderson Tvedt, et al.
Published: (2017-06-01)

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis
by: Jon-Magnus Tangen, et al.
Published: (2018-08-01)

Framing culture: VCD music videos and the politics of genre in the Peruvian Andes
by: Butterworth, J
Published: (2017)

Pengurusan jenazah wanita : kematian satu keinsafan (3VCD/set)
by: Nasiah Abd.Razak
Published: ([200)

Sistem penjualan VCD berasaskan web syarikat Beyond [electronic resource] /
by: 235866 Anand Verdamanickam
Published: (2005)

VCD-induced menopause mouse model reveals reprogramming of hepatic metabolism
by: Roshan Kumari, et al.
Published: (2024-04-01)

PB2163: BORTEZOMIB - CYCLOPHOSPHAMIDE – DEXAMETHASONE (VCD) REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) - EXPERIENCE FROM A RESOURCE CONSTRAINT SETTING IN SOUTH INDIA
by: Rahmathullah Sulaimankutty Nameera, et al.
Published: (2023-08-01)

P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
by: J. N. Nørgaard, et al.
Published: (2022-06-01)

P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW.
by: Michael Gundesen, et al.
Published: (2023-08-01)

Efficacy and outcome of autologous transplantation in rare myelomas
by: Curly Morris, et al.
Published: (2010-12-01)

VCD karaoke doa-doa berserta ulasan ringkas [cakera padat video]
Published: (1999)

Mengembangkan Kemampuan Pemahaman Konsep Peserta Didik Melalui Pembelajaran Berbasis VCD
by: Farida Farida
Published: (2015-06-01)

Toxic effects of VCD on kidneys and liver tissues: a histopathological and biochemical study
by: Shahin Ahmadian, et al.
Published: (2019-07-01)

Pengembangan Media VCD Pembelajaran "Memerankan Drama Pendek" di Sekolah Dasar
by: Siti Mariyah
Published: (2005-12-01)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
by: Anne Marit Sponaas, et al.
Published: (2021-02-01)